FATE Fate Therapeutics Inc.
Fundamentals / CIK 0001434316 / USDFate Therapeutics Inc. reported $4.75M in revenue and a net loss of $124.4M for the trailing twelve months ended September 30, 2026 (down 100.0% year over year), with a -2760.0% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open FATE in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$4.75M -100.0% YoY
-
Operating Income TTM-$131.1M -2760.0% margin
-
Net Income TTM-$124.4M -2619.6% net margin
-
Diluted EPS TTM-$1.01 Split-adjusted
-
Free Cash Flow TTM-$106.8M -2249.4% FCF margin
-
Cash & ST Investments Sep 30, 2026$139.1M Total debt: $74.49M
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.65M | $13.63M | $63.53M | $96.30M | $55.85M | $31.43M | $10.68M | $4.74M | $4.11M | $4.40M |
| Research & Development | $107.8M | $135.0M | $172.6M | $320.5M | $215.5M | $125.6M | $87.77M | $56.02M | $34.36M | $26.45M |
| Total Operating Expenses | $154.3M | $223.9M | $254.0M | $404.7M | $272.8M | $159.5M | $111.4M | $71.83M | $46.23M | $36.37M |
| Operating Income | -$147.7M | -$210.3M | -$190.5M | -$308.4M | -$217.0M | -$128.1M | -$100.7M | -$67.09M | -$42.12M | -$31.96M |
| EBITDA | -$134.8M | -$191.3M | -$172.2M | -$294.6M | -$211.1M | -$125.0M | -$98.53M | -$65.89M | -$41.15M | -$31.08M |
| Interest Income | $11.05M | $17.29M | $17.19M | $5.84M | $1.31M | $2.40M | $4.33M | $2.19M | $559K | $138K |
| Interest Expense | -- | -- | -- | -- | $0 | $0 | $1.75M | $1.70M | $1.27M | $1.64M |
| Income Tax Expense | $2.0K | $0 | $0 | $0 | $0 | $0 | $0 | -- | -- | -- |
| Net Income | -$136.3M | -$186.3M | -$160.9M | -$281.7M | -$212.2M | -$173.4M | -$98.15M | -$66.60M | -$42.95M | -$33.46M |
| Basic EPS | -$1.15 | -$1.64 | -$1.64 | -$2.91 | -$2.24 | -$2.10 | -$1.44 | -$1.19 | -$1.02 | -$1.05 |
| Diluted EPS | -$1.15 | -$1.64 | -$1.64 | -$2.91 | -$2.24 | -$2.10 | -$1.44 | -$1.19 | -$1.02 | -$1.05 |
| Basic Shares Outstanding | 118.8M | 113.7M | 98.4M | 96.8M | 94.7M | 82.4M | 68.2M | 56.2M | 42.0M | 31.8M |
| Diluted Shares Outstanding | 118.8M | 113.7M | 98.4M | 96.8M | 94.7M | 82.4M | 68.2M | 56.2M | 42.0M | 31.8M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $2.08M | $1.30M | $1.37M | $1.74M | $1.91M | $1.63M | $1.86M |
| Research & Development | $24.21M | $24.39M | $24.70M | $25.43M | $25.84M | $27.43M | $29.14M | $33.61M |
| Total Operating Expenses | $32.25M | $33.22M | $34.30M | $36.09M | $36.48M | $38.88M | $42.91M | $63.61M |
| Operating Income | -$32.25M | -$31.13M | -$33.00M | -$34.72M | -$34.73M | -$36.97M | -$41.28M | -$61.75M |
| EBITDA | -$29.57M | -$28.35M | -$30.08M | -$31.66M | -$31.51M | -$33.69M | -$37.95M | -$56.94M |
| Interest Income | $1.41M | $1.55M | $1.87M | $2.22M | $2.58M | $2.92M | $3.34M | $3.87M |
| Net Income | -$30.69M | -$30.16M | -$31.21M | -$32.37M | -$32.25M | -$34.07M | -$37.62M | -$52.15M |
| Basic EPS | -$0.25 | -$0.25 | -$0.26 | -- | -$0.27 | -$0.29 | -$0.32 | -- |
| Diluted EPS | -$0.25 | -$0.25 | -$0.26 | -- | -$0.27 | -$0.29 | -$0.32 | -- |
| Basic Shares Outstanding | 123.7M | 120.4M | 120.0M | -- | 119.0M | 118.5M | 118.4M | -- |
| Diluted Shares Outstanding | 123.7M | 120.4M | 120.0M | -- | 119.0M | 118.5M | 118.4M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $46.63M | $36.06M | $41.87M | $61.33M | $133.6M | $167.3M | $99.81M | $190.5M | $88.95M | $88.61M |
| Short-Term Investments | $157.0M | $243.0M | $273.3M | $374.9M | $482.3M | -- | -- | -- | -- | $3.50M |
| Cash & Short-Term Investments | $203.7M | $279.1M | $315.2M | $436.2M | $615.9M | $167.3M | $99.81M | $190.5M | $88.95M | $92.11M |
| Accounts Receivable, Net | $916K | $3.54M | $1.83M | $38.48M | $8.68M | $5.51M | -- | $500K | -- | -- |
| Total Current Assets | $208.7M | $291.9M | $331.5M | $502.1M | $633.4M | $494.3M | $227.1M | $205.2M | $102.6M | $93.32M |
| Property, Plant & Equipment, Net | $56.92M | $64.38M | $96.84M | $110.0M | $91.53M | $32.31M | $11.42M | $5.12M | $2.55M | $1.58M |
| Long-Term Investments | $1.47M | $27.66M | $980K | $4.94M | $100.7M | -- | $39.44M | -- | -- | -- |
| Other Non-Current Assets | $0 | $9.0K | $9.0K | $33K | $33K | $9.0K | $9.0K | $526K | $24K | $24K |
| Total Non-Current Assets | $110.2M | $148.8M | $174.7M | $203.5M | $288.0M | $128.1M | $75.19M | $7.84M | $2.70M | $1.73M |
| Total Assets | $318.9M | $440.7M | $506.2M | $705.6M | $921.5M | $622.5M | $302.3M | $213.0M | $105.3M | $95.05M |
| Accounts Payable | $2.66M | $9.37M | $4.72M | $8.27M | $8.61M | $6.28M | $5.82M | $4.21M | $1.68M | $934K |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | -- | $2.44M | -- | $8.19M |
| Deferred Revenue (Current) | $381K | $393K | $685K | $42.23M | $21.48M | $21.14M | $2.79M | $7.59M | $2.10M | $2.10M |
| Total Current Liabilities | $36.07M | $38.52M | $39.09M | $114.1M | $81.28M | $85.56M | $27.81M | $27.26M | $11.05M | $15.19M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | -- | $12.45M | $14.81M | $2.50M |
| Deferred Revenue (Non-Current) | -- | -- | -- | $0 | $27.12M | $46.02M | $3.77M | $7.50M | $724K | $2.83M |
| Total Non-Current Liabilities | $75.68M | $83.45M | $98.71M | $107.6M | $161.3M | $152.4M | $29.71M | $25.30M | $17.05M | $6.71M |
| Total Liabilities | $111.8M | $122.0M | $137.8M | $221.6M | $242.6M | $238.0M | $57.52M | $52.56M | $28.10M | $21.89M |
| Total Debt (incl. Leases) | $77.85M | $85.27M | $103.5M | $109.3M | $114.8M | $97.30M | $26.93M | $14.88M | $14.81M | $10.69M |
| Common Stock | $115K | $114K | $99K | $97K | $96K | $88K | $76K | $65K | $53K | $41K |
| Retained Earnings | -$1.53B | -$1.40B | -$1.21B | -$1.05B | -$769.1M | -$556.9M | -$383.5M | -$285.4M | -$218.8M | -$175.8M |
| Accumulated Other Comp. Income | $116K | $268K | $15K | -$1.85M | -$762K | $70K | $22K | -$2.0K | -$3.0K | -$1.0K |
| Total Stockholders' Equity | $207.2M | $318.7M | $368.4M | $483.9M | $678.8M | $384.4M | $244.8M | $160.5M | $77.19M | $73.15M |
| Total Equity | $207.2M | $318.7M | $368.4M | $483.9M | $678.8M | $384.4M | $244.8M | $160.5M | $77.19M | $73.15M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $43.94M | $32.43M | $39.57M | $46.63M | $40.62M | $41.25M | $44.92M | $36.06M |
| Short-Term Investments | $95.19M | $121.3M | $135.3M | $157.0M | $174.8M | $181.6M | $195.5M | $243.0M |
| Cash & Short-Term Investments | $139.1M | $153.8M | $174.8M | $203.7M | $215.4M | $222.8M | $240.4M | $279.1M |
| Accounts Receivable, Net | $479K | $703K | $704K | $916K | $682K | $1.40M | $2.41M | $3.54M |
| Total Current Assets | $144.3M | $158.0M | $179.5M | $208.7M | $221.3M | $230.4M | $248.2M | $291.9M |
| Property, Plant & Equipment, Net | $48.91M | $51.55M | $54.26M | $56.92M | $59.48M | $61.10M | $62.76M | $64.38M |
| Long-Term Investments | $0 | $0 | $0 | $1.47M | $10.30M | $26.10M | $32.29M | $27.66M |
| Other Non-Current Assets | -- | -- | -- | $0 | $0 | $0 | $0 | $9.0K |
| Total Non-Current Assets | $94.02M | $102.2M | $105.4M | $110.2M | $122.4M | $141.2M | $150.5M | $148.8M |
| Total Assets | $238.3M | $260.1M | $284.9M | $318.9M | $343.7M | $371.6M | $398.7M | $440.7M |
| Accounts Payable | $2.92M | $3.26M | $3.28M | $2.66M | $3.50M | $4.04M | $4.19M | $9.37M |
| Deferred Revenue (Current) | $0 | $0 | $582K | $381K | $5.0K | $0 | $212K | $393K |
| Total Current Liabilities | $32.69M | $32.59M | $30.69M | $36.07M | $28.11M | $28.67M | $28.16M | $38.52M |
| Total Non-Current Liabilities | $72.55M | $74.07M | $74.52M | $75.68M | $81.49M | $81.59M | $82.10M | $83.45M |
| Total Liabilities | $105.2M | $106.7M | $105.2M | $111.8M | $109.6M | $110.3M | $110.3M | $122.0M |
| Total Debt (incl. Leases) | $74.49M | $75.67M | $76.78M | $77.85M | $79.25M | $81.33M | $83.33M | $85.27M |
| Common Stock | $122K | $117K | $116K | $115K | $115K | $115K | $115K | $114K |
| Retained Earnings | -$1.63B | -$1.60B | -$1.57B | -$1.53B | -$1.50B | -$1.47B | -$1.44B | -$1.40B |
| Accumulated Other Comp. Income | -$155K | -$117K | -$77K | $116K | $153K | $62K | $191K | $268K |
| Total Stockholders' Equity | $133.0M | $153.4M | $179.7M | $207.2M | $234.1M | $261.4M | $288.4M | $318.7M |
| Total Equity | $133.0M | $153.4M | $179.7M | $207.2M | $234.1M | $261.4M | $288.4M | $318.7M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$136.3M | -$186.3M | -$160.9M | -$281.7M | -$212.2M | -$173.4M | -$98.15M | -$66.60M | -$42.95M | -$33.46M |
| Depreciation & Amortization | $12.90M | $18.96M | $18.28M | $13.76M | $5.85M | $3.09M | $2.19M | $1.20M | $971K | $881K |
| Stock-Based Compensation | $24.92M | $41.50M | $43.46M | $78.73M | $54.36M | $30.75M | $17.41M | $6.29M | $3.61M | $3.18M |
| Change in Receivables | $2.62M | -$1.11M | $36.65M | -$29.80M | -$3.16M | -$5.51M | $500K | -$500K | -- | -- |
| Operating Cash Flow | -$106.1M | -$122.9M | -$132.3M | -$248.2M | -$162.9M | -$39.23M | -$83.17M | -$38.65M | -$36.82M | -$29.82M |
| Capital Expenditure | -$5.95M | -$730K | -$6.15M | -$35.57M | -$50.70M | -$4.93M | -$7.39M | -$2.30M | -$1.73M | -$457K |
| Free Cash Flow | -$112.0M | -$123.6M | -$138.4M | -$283.8M | -$213.6M | -$44.16M | -$90.57M | -$40.95M | -$38.54M | -$30.28M |
| Purchases of Investments | -$195.1M | -$317.8M | -$358.8M | -$404.8M | -$968.2M | -$277.3M | -$248.9M | -$55.66M | -$39.97M | -- |
| Sales & Maturities of Investments | $311.9M | $330.7M | $477.6M | $607.1M | $694.8M | $121.2M | $98.80M | $57.50M | $31.50M | -- |
| Investing Cash Flow | $111.2M | $12.22M | $112.7M | $166.8M | -$324.0M | -$161.1M | -$157.5M | -$463K | -$10.20M | -$4.11M |
| Common Stock Issued | -- | -- | -- | -- | $411.7M | $188.8M | $162.4M | $134.6M | $43.21M | -- |
| Financing Cash Flow | $5.49M | $99.89M | $85K | $9.21M | $453.1M | $282.8M | $149.9M | $140.8M | $47.36M | $57.74M |
| Net Change in Cash | $10.57M | -$10.76M | -$19.51M | -$72.25M | -$33.76M | $82.53M | -$90.70M | $101.7M | $343K | $23.80M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$30.69M | -$30.16M | -$31.21M | -$32.37M | -$32.25M | -$34.07M | -$37.62M | -$52.15M |
| Depreciation & Amortization | $2.68M | $2.78M | $2.92M | $3.06M | $3.23M | $3.28M | $3.33M | $4.81M |
| Stock-Based Compensation | $2.70M | $3.52M | $3.93M | $5.53M | $4.86M | $7.15M | $7.38M | $9.12M |
| Change in Receivables | $224K | $1.0K | $212K | -$233K | $713K | $1.01M | $1.13M | $588K |
| Operating Cash Flow | -$27.80M | -$23.40M | -$30.82M | -$23.31M | -$24.37M | -$24.59M | -$33.81M | -$27.80M |
| Capital Expenditure | $0 | -$80K | -$239K | -$1.19M | -$2.20M | -$1.36M | -$1.20M | -$98K |
| Free Cash Flow | -$27.80M | -$23.48M | -$31.06M | -$24.51M | -$26.58M | -$25.95M | -$35.01M | -$27.90M |
| Purchases of Investments | -$17.66M | -$58.35M | -$28.73M | -$37.73M | -$57.98M | -$50.81M | -$48.62M | -$38.01M |
| Sales & Maturities of Investments | $44.50M | $72.98M | $52.55M | $66.32M | $81.45M | $71.64M | $92.49M | $60.92M |
| Investing Cash Flow | $26.84M | $14.56M | $23.59M | $27.63M | $21.27M | $19.59M | $42.67M | $22.82M |
| Common Stock Issued | $7.60M | -- | -- | -- | -- | -- | -- | -- |
| Financing Cash Flow | -- | -- | -- | $1.69M | $2.48M | $1.32M | $0 | $3.13M |
| Net Change in Cash | $6.56M | -$7.14M | -$7.24M | $6.01M | -$627K | -$3.67M | $8.86M | -$1.85M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2222.4% | -1542.6% | -299.9% | -320.2% | -388.6% | -407.5% | -943.1% | -1415.4% | -1025.9% | -726.1% |
| Net Profit Margin | -2051.1% | -1366.5% | -253.3% | -292.5% | -379.9% | -551.6% | -919.0% | -1405.0% | -1046.1% | -760.2% |
| Return on Equity (ROE) | -65.8% | -58.4% | -43.7% | -58.2% | -31.3% | -45.1% | -40.1% | -41.5% | -55.6% | -45.7% |
| Return on Assets (ROA) | -42.7% | -42.3% | -31.8% | -39.9% | -23.0% | -27.9% | -32.5% | -31.3% | -40.8% | -35.2% |
| Current Ratio | 5.79x | 7.58x | 8.48x | 4.40x | 7.79x | 5.78x | 8.17x | 7.53x | 9.29x | 6.14x |
| Quick Ratio | 5.67x | 7.34x | 8.11x | 4.16x | 7.68x | 2.02x | 3.59x | 7.01x | 8.05x | 6.07x |
| Debt to Equity | 0.38x | 0.27x | 0.28x | 0.23x | 0.17x | 0.25x | 0.11x | 0.09x | 0.19x | 0.15x |
| Revenue Growth (YoY) | -51.2% | -78.5% | -34.0% | +72.4% | +77.7% | +194.3% | +125.3% | +15.4% | -6.7% | +81.1% |
| 5Y Revenue / Share Growth | -85.3% | -23.4% | +665.4% | +916.9% | +325.2% | +300.0% | -- | -48.8% | -96.0% | -90.2% |
| 10Y Revenue / Share Growth | -41.4% | -- | +292.0% | -59.4% | -58.1% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2760.0% | -2058.1% | -2207.5% | -2222.4% | -2448.2% | -2271.2% | -1503.5% | -1542.6% |
| Net Profit Margin | -2619.6% | -1941.1% | -2056.8% | -2051.1% | -2187.1% | -2025.1% | -1318.9% | -1366.5% |
| Return on Equity (ROE) | -93.5% | -82.1% | -72.3% | -65.8% | -66.7% | -65.6% | -61.0% | -58.4% |
| Return on Assets (ROA) | -52.2% | -48.4% | -45.6% | -42.7% | -45.4% | -46.2% | -44.1% | -42.3% |
| Current Ratio | 4.41x | 4.85x | 5.85x | 5.79x | 7.87x | 8.04x | 8.81x | 7.58x |
| Quick Ratio | 4.27x | 4.74x | 5.72x | 5.67x | 7.69x | 7.82x | 8.62x | 7.34x |
| Debt to Equity | 0.56x | 0.49x | 0.43x | 0.38x | 0.34x | 0.31x | 0.29x | 0.27x |
| Revenue Growth (YoY) | -100.0% | +9.2% | -20.3% | -26.4% | -43.4% | -71.8% | -15.4% | +11.0% |